Last $18.62 USD
Change Today +0.74 / 4.14%
Volume 41.2K
GNCA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kevin J. Bitterman Ph.D.

Interim Chief Executive Officer and Interim President, Editas Medicine Inc.
AgeTotal Calculated CompensationThis person is connected to 81 board members in 9 different organizations across 11 different industries.

See Board Relationships
37--

Background*

Dr. Kevin J. Bitterman, Ph.D. is a Partner at Polaris Venture Partners. He was a Principal at the firm. Dr. Bitterman joined Polaris Partners in July 2004 and focuses on investments in the life sciences. He is a Board Observer to Arsenal Medical and 480 Biomedical. He serves as an Interim Chief Executive Officer and Interim President at Editas Medicine Inc. He was a Co-Founder of Sirtris Pharmaceuticals, Inc. and serves as its Business Development cum Biology Consultant. ...

Read Full Background

Corporate Headquarters*

100 Acorn Park Drive
Cambridge, Massachusetts 02140

United States

Phone: 617-876-8191
Fax: --

Board Members Memberships*

Director
Former Board Observer
Director
Director
Director
Director
2006-Present
Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
2007-Present
Director
2008-Present
Director
2011-Present
Director

Education*

BA
Rutgers, The State University of New Jersey
PhD
Harvard Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNCA:US $18.62 USD +0.74

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOCEA BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.